176 related articles for article (PubMed ID: 18477489)
1. Injectable contraception: what should the longest interval be for reinjections?
Steiner MJ; Kwok C; Stanback J; Byamugisha JK; Chipato T; Magwali T; Mmiro F; Rugpao S; Sriplienchan S; Morrison C
Contraception; 2008 Jun; 77(6):410-4. PubMed ID: 18477489
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy risk among oral contraceptive pill, injectable contraceptive, and condom users in Uganda, zimbabwe, and Thailand.
Steiner MJ; Kwok C; Dominik R; Byamugisha JK; Chipato T; Magwali T; Mmiro F; Rugpao S; Sriplienchan S; Morrison CS
Obstet Gynecol; 2007 Nov; 110(5):1003-9. PubMed ID: 17978111
[TBL] [Abstract][Full Text] [Related]
3. Hormonal contraception and the risk of HIV acquisition.
Morrison CS; Richardson BA; Mmiro F; Chipato T; Celentano DD; Luoto J; Mugerwa R; Padian N; Rugpao S; Brown JM; Cornelisse P; Salata RA;
AIDS; 2007 Jan; 21(1):85-95. PubMed ID: 17148972
[TBL] [Abstract][Full Text] [Related]
4. Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch?
Thurman AR; Hammond N; Brown HE; Roddy ME
J Pediatr Adolesc Gynecol; 2007 Apr; 20(2):61-5. PubMed ID: 17418388
[TBL] [Abstract][Full Text] [Related]
5. Initiation and continuation rates seen in 2-year experience with Same Day injections of DMPA.
Nelson AL; Katz T
Contraception; 2007 Feb; 75(2):84-7. PubMed ID: 17241834
[TBL] [Abstract][Full Text] [Related]
6. Facts about injectable contraceptives: memorandum from a WHO meeting.
Bull World Health Organ; 1982; 60(2):199-210. PubMed ID: 6213318
[TBL] [Abstract][Full Text] [Related]
7. Implanon as a contraceptive choice for teenage mothers: a comparison of contraceptive choices, acceptability and repeat pregnancy.
Lewis LN; Doherty DA; Hickey M; Skinner SR
Contraception; 2010 May; 81(5):421-6. PubMed ID: 20399949
[TBL] [Abstract][Full Text] [Related]
8. Depo-Provera: use of a long-acting progestin injectable contraceptive in Turkish women.
Aktun H; Moroy P; Cakmak P; Yalcin HR; Mollamahmutoglu L; Danisman N
Contraception; 2005 Jul; 72(1):24-7. PubMed ID: 15964288
[TBL] [Abstract][Full Text] [Related]
9. Immediate monthly combination contraception to facilitate initiation of the depot medroxyprogesterone acetate contraceptive injection.
Morroni C; Grams M; Tiezzi L; Westhoff C
Contraception; 2004 Jul; 70(1):19-23. PubMed ID: 15208048
[TBL] [Abstract][Full Text] [Related]
10. Continuation of subcutaneous or intramuscular injectable contraception when administered by facility-based and community health workers: findings from a prospective cohort study in Burkina Faso and Uganda.
MacLachlan E; Atuyambe LM; Millogo T; Guiella G; Yaro S; Kasasa S; Bukenya J; Nyabigambo A; Mubiru F; Tumusiime J; Onadja Y; Zan LM; Goeum/Sanon C; Kouanda S; Namagembe A
Contraception; 2018 Nov; 98(5):423-429. PubMed ID: 30125558
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal study of depot medroxyprogesterone acetate (Depo-Provera) effects on bone health in adolescents: study design, population characteristics and baseline bone mineral density.
Johnson CC; Burkman RT; Gold MA; Brown RT; Harel Z; Bruner A; Stager M; Bachrach LK; Hertweck SP; Nelson AL; Nelson DA; Coupey SM; McLeod A; Bone HG
Contraception; 2008 Apr; 77(4):239-48. PubMed ID: 18342646
[TBL] [Abstract][Full Text] [Related]
12. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception.
Scholes D; LaCroix AZ; Ichikawa LE; Barlow WE; Ott SM
Arch Pediatr Adolesc Med; 2005 Feb; 159(2):139-44. PubMed ID: 15699307
[TBL] [Abstract][Full Text] [Related]
13. Continuation of injectable contraception when self-injected vs. administered by a facility-based health worker: a nonrandomized, prospective cohort study in Uganda.
Cover J; Namagembe A; Tumusiime J; Nsangi D; Lim J; Nakiganda-Busiku D
Contraception; 2018 Nov; 98(5):383-388. PubMed ID: 29654751
[TBL] [Abstract][Full Text] [Related]
14. Preference for Sayana® Press versus intramuscular Depo-Provera among HIV-positive women in Rakai, Uganda: a randomized crossover trial.
Polis CB; Nakigozi GF; Nakawooya H; Mondo G; Makumbi F; Gray RH;
Contraception; 2014 May; 89(5):385-95. PubMed ID: 24332432
[TBL] [Abstract][Full Text] [Related]
15. [An introductory clinical trial of three-monthly injectable contraceptive-depot medroxyprogesterone acetate].
Shao Q; Jiang H; Fu W
Zhonghua Fu Chan Ke Za Zhi; 1999 Jan; 34(1):36-9. PubMed ID: 11263172
[TBL] [Abstract][Full Text] [Related]
16. Researcher explains status of Depo Provera. [Answer to question of Marienetta Blackwell].
Greenspan A
Contracept Technol Update; 1981 Mar; 2(3):35-6. PubMed ID: 12337540
[TBL] [Abstract][Full Text] [Related]
17. [Depot medroxyprogesterone acetate (DMPA) injectable contraception--safe, effective but neglected method of family planning in Poland].
Lech MM
Wiad Lek; 2003; 56(7-8):362-8. PubMed ID: 14969166
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.
Kaunitz AM; Darney PD; Ross D; Wolter KD; Speroff L
Contraception; 2009 Jul; 80(1):7-17. PubMed ID: 19501210
[TBL] [Abstract][Full Text] [Related]
19. Demographic analysis of post-abortive and interval-administered hormonal contraceptive methods.
Ertopçu K; Inal MM; Ozelmas I
Eur J Contracept Reprod Health Care; 2005 Mar; 10(1):1-5. PubMed ID: 16036290
[TBL] [Abstract][Full Text] [Related]
20. The use of depot-medroxyprogesterone acetate in contraception and its potential impact on skeletal health.
Guilbert ER; Brown JP; Kaunitz AM; Wagner MS; Bérubé J; Charbonneau L; Francoeur D; Gilbert A; Gilbert F; Roy G; Senikas V; Jacob R; Morin R
Contraception; 2009 Mar; 79(3):167-77. PubMed ID: 19185668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
